Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Anatomy Item Literature (4863) Expression Attributions Wiki
XB-ANAT-511

Papers associated with nerve (and grin2b)

Limit to papers also referencing gene:
Show all nerve papers
???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

Functional limb muscle innervation prior to cholinergic transmitter specification during early metamorphosis in Xenopus., Lambert FM., Elife. May 30, 2018; 7                     


Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors., Masuko T., J Pharmacol Exp Ther. November 1, 2009; 331 (2): 522-30.


Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors., Cavara NA., BMC Neurosci. April 6, 2009; 10 32.      


Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors., Mony L., Mol Pharmacol. January 1, 2009; 75 (1): 60-74.


Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor., Han X., J Neurochem. December 1, 2008; 107 (6): 1566-77.


Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission., Frizelle PA., Mol Pharmacol. September 1, 2006; 70 (3): 1022-32.


Nickel differentially affects NMDA receptor channels in developing cultured rat neurons., Gavazzo P., Dev Biol. March 17, 2006; 1078 (1): 71-9.


Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis., Hansen KB., Mol Pharmacol. December 1, 2005; 68 (6): 1510-23.


NMDA receptors as targets of heavy metal interaction and toxicity., Marchetti C., Neurotox Res. November 1, 2005; 8 (3-4): 245-58.


Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids., Conti P., J Med Chem. October 6, 2005; 48 (20): 6315-25.


Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket., Kinarsky L., J Pharmacol Exp Ther. June 1, 2005; 313 (3): 1066-74.


Corymine potentiates NMDA-induced currents in Xenopus oocytes expressing NR1a/NR2B glutamate receptors., Leewanich P., J Pharmacol Sci. May 1, 2005; 98 (1): 58-65.


Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists., Morley RM., J Med Chem. April 7, 2005; 48 (7): 2627-37.


The effect of competitive antagonist chain length on NMDA receptor subunit selectivity., Feng B., Neuropharmacology. March 1, 2005; 48 (3): 354-9.


The micromolar zinc-binding domain on the NMDA receptor subunit NR2B., Rachline J., J Neurosci. January 12, 2005; 25 (2): 308-17.


Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner., Masuko T., Neurosci Lett. November 16, 2004; 371 (1): 30-3.


Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst EPSC in rat hippocampus., Lozovaya NA., J Physiol. July 15, 2004; 558 (Pt 2): 451-63.


A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity., Jang MK., Proc Natl Acad Sci U S A. May 25, 2004; 101 (21): 8198-8203.


Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins., Iwamoto T., J Neurochem. April 1, 2004; 89 (1): 100-8.


Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid., Feng B., Br J Pharmacol. February 1, 2004; 141 (3): 508-16.


Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket., Malherbe P., J Pharmacol Exp Ther. December 1, 2003; 307 (3): 897-905.


Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner., Levine JB., Neurosci Lett. August 7, 2003; 346 (3): 125-8.


Structural model of the N-methyl-D-aspartate receptor glycine site probed by site-directed chemical coupling., Foucaud B., J Biol Chem. June 27, 2003; 278 (26): 24011-7.


ATP inhibits NMDA receptors after heterologous expression and in cultured hippocampal neurons and attenuates NMDA-mediated neurotoxicity., Ortinau S., J Neurosci. June 15, 2003; 23 (12): 4996-5003.


Oxygen sensitivity of NMDA receptors: relationship to NR2 subunit composition and hypoxia tolerance of neonatal neurons., Bickler PE., Neuroscience. January 1, 2003; 118 (1): 25-35.

???pagination.result.page??? 1